< Return to all Tests

Test Category: Specialist Biochemistry

Investigation Name:Caffeine

Accreditation:UKAS ISO15189:2022 Accredited test: On scope

Intro:

Caffeine is consumed by more than 90% of adults daily and is found in coffee, tea, chocolate and energy drinks. It is also combined with analgesics and produced in a tablet form for fatigue relief. Caffeine and its main metabolite paraxanthine are both central nervous system stimulants which, among other effects, can increase blood pressure and accentuate heart beats. Caffeine also has psychoactive properties leading to reduced fatigue and increased alertness. Excessive consumption of caffeine and subsequent withdrawal can lead to non-specific side-effects such as anxiety, depression, palpitations, migraine and insomnia.
Caffeine therapy is commonly used to treat apnoea of prematurity in pre-term infants and is well noted to reduce apnoea, intermittent hypoxia, and extubating failure if the infant is mechanically ventilated.

Requestable Seperately?Yes

Expected Turnaround Time:3 working days. Urgent analysis where clinically indicated may be arranged directly with the laboratory.

Sample Type:

A minimum volume of 500μL is required for the following samples:
• Urine in a plain universal
• Serum or plasma (from a neonatal lithium heparin tube)
• Saliva collected using a suitable collection device such as the Oracol device

Complex Reference Range:Serum: Neonates:12 – 36 mg/L (1-2 hours post dose)
Adults:
Normal < 2.0 mg/
High 2.0 - 5.0 mg/L
Very high > 5.0 mg/L
Random Urine:
Adults Normal < 0.50 mg/mmol
High 0.50 - 1.75 mg/mmol
Very high > 1.75 mg/mmol

Collection Conditions / Other Information:Serum samples need to be collected 1-2 hours post dose in neonates receiving therapy.

Referred to Another Laboratory?No

Storage Requirements:4°C prior to postage.

Posting Address / Requirements:Ambient temperature, 1st Class Post.
Sandwell Health Campus,
Specialist Chemistry,
Pathology Department,
Lyndon B71 4HJ

NPEX / PDF Reporting Available:Yes

EQA Scheme:UK NEQAS TDM scheme.

Lead Contact Details:Consultant Clinical Scientist, Hayley Sharrod-Cole
Email:hayley.sharrod-cole@nhs.net

Email Address For Chasing Results:rwh-tr.bcpsspecialistchemistryenquiries@nhs.net

Site Sample Tested:Manuals Laboratory - Sandwell Health Campus

Cost:Please email: bcpspathology.info@nhs.net for further details

Contact Number:0121 507 5162